Table IV.
Distribution and identification of new intramammary infections for the 2 intramammary treatment regimens using ceftiofur: Standard 2 day therapy (2d group) and extended therapy (8d group) at 7, 14, and 21 d after the end of the treatments
| Treatment group | Follow-up period | ||
|---|---|---|---|
|
| |||
| 7 d | 14 d | 21 d | |
| 2d | 1 S. aureus | 1 Serratia spp. | 1 CNS |
| 1 CNS | 1 Corynebacterium spp. | 1 Enterococcus spp. | |
| 1 Corynebacterium spp. | 1 CNS | 1 Corynebacterium spp. | |
| 1 Str. dysgalactiae | |||
| 8d | 1 S. aureus | 1 S. aureus | 1 Corynebacterium spp. |
| 1 CNS | 2 CNS | ||
CNS — coagulase negative staphylococci.